Search

Wai Hung Wong

from Kirkland, WA
Age ~71
Get Report
Also known as:
Wai H Wong, Wai Hon Wong
Related to:
Linda M Webster, 62Alice WongKin H WongMindi N Ng, 65
Connected to:
Adela U Wong, 60Aidan Wong, 41Alec J Wong, 47Allison Wong, 57Alpha J Wong, 49Amoy B Wong, 72Andrea G Wong, 75Anthony WongArden M Wong, 77Arno K Wong, 75

Wai Wong Phones & Addresses

  • Kirkland, WA
  • Bellevue, WA
  • Brooklyn, NY
  • Flushing, NY
  • New York, NY

Professional Records

Medicine Doctors

Wai Wong Photo 1

Dr. Wai Y Wong, New York NY - MD (Doctor of Medicine)

View page
Specialties:
Pediatrics
Age:
42
Address:
550 1St Ave, New York, NY 10016
(212) 263-5506 (Phone), (212) 263-7300 (Fax)

CHILDRENS HOSPITAL BOSTON
300 Longwood Ave, Boston, MA 02115
(617) 355-6117 (Phone), (617) 738-7066 (Fax)
Languages:
English
Education:
Medical School
Stony Brook Univ Hsc Sch Med
Graduated: 2010
Wai Wong Photo 2

Wai Y Wong, Redmond WA - PT (Physical therapy)

View page
Specialties:
Physical Therapy
Address:
2569 152Nd Ave Ne, Redmond, WA 98052
(425) 497-8180 (Phone), (425) 497-8358 (Fax)
Languages:
English
Wai Wong Photo 3

Wai Shun Wong

View page
Specialties:
Interventional Cardiology, Cardiovascular Disease
Work:
Beaumont Academic Heart & Vascular Group
3601 W 13 Mile Rd FL 3, Royal Oak, MI 48073
(248) 898-4163 (phone), (248) 898-5596 (fax)
Education:
Medical School
Tufts University School of Medicine
Graduated: 1999
Procedures:
Cardiac Catheterization
Cardioversion
Continuous EKG
Echocardiogram
Electrocardiogram (EKG or ECG)
Pacemaker and Defibrillator Procedures
Conditions:
Acute Myocardial Infarction (AMI)
Anemia
Angina Pectoris
Aortic Valvular Disease
Atrial Fibrillation and Atrial Flutter
Languages:
English
Description:
Dr. Wong graduated from the Tufts University School of Medicine in 1999. He works in Royal Oak, MI and specializes in Interventional Cardiology and Cardiovascular Disease. Dr. Wong is affiliated with William Beaumont Hospital.
Wai Wong Photo 4

Wai Wong

View page
Specialties:
Internal Medicine
Work:
Kawoo Medical Clinic Inc
841 W Vly Blvd STE 107, Alhambra, CA 91803
(626) 282-3657 (phone), (626) 282-2759 (fax)
Languages:
Chinese
English
Spanish
Description:
Ms. Wong works in Alhambra, CA and specializes in Internal Medicine. Ms. Wong is affiliated with Alhambra Hospital Medical Center, Garfield Medical Center and San Gabriel Valley Medical Center.
Wai Wong Photo 5

Wai Wong, New York NY

View page
Specialties:
Internal Medicine
Work:
Wai Y Chung
550 1St Ave, New York, NY 10016
P&S 11-508
630 W 168Th St, New York, NY 10032
Education:
Yale University
Wai Wong Photo 6

Wai Thong Wong

View page
Specialties:
Ophthalmology
Education:
Washington University at St. Louis (2001)

Lawyers & Attorneys

Wai Wong Photo 7

Wai Tung Juanita Wong, Staten Island NY - Lawyer

View page
Address:
Juanita Wong, Esq.
185 Beach Ave, Staten Island, NY 10306
(212) 962-7200 (Office)
Licenses:
New York - Currently registered 1988
Education:
University of London School of Law
Wai Wong Photo 8

Wai Chi Wong - Lawyer

View page
Address:
Invesco Hong Kong Limited
(312) 860-00xx (Office)
Licenses:
New York - Currently registered 2007
Education:
University of Hong Kong
Wai Wong Photo 9

Wai Ho Leo Wong, New York NY - Lawyer

View page
Address:
Shearman and Sterling LLP
599 Lexington Ave, New York, NY 10022
(212) 848-4259 (Office)
Licenses:
New York - Currently registered 2013
Education:
The George Washington University Law School
Wai Wong Photo 10

Wai Wong

Wai Wong Photo 11

Wai M Wong

Wai Wong Photo 12

Wai Wong - Lawyer

View page
Office:
Arculli & Fong
ISLN:
919728910
Admitted:
2006
Wai Wong Photo 13

Wai Wong - Lawyer

View page
ISLN:
910671659
Admitted:
1988
University:
University of London
Wai Wong Photo 14

Wai Ling Wong

License Records

Wai Wong

Address:
205 Sackett St, Brooklyn, NY
License #:
30162 - Expired
Category:
Health Care
Issued Date:
Mar 13, 1995
Effective Date:
Oct 15, 2013
Expiration Date:
Sep 30, 2011
Type:
Pharmacist

Public records

Vehicle Records

Wai Wong

View page
Address:
2180 W 6 St, Brooklyn, NY 11223
VIN:
1J8FF47W07D422890
Make:
JEEP
Model:
COMPASS
Year:
2007

Business Records

Name / Title
Company / Classification
Phones & Addresses
Wai Yip Wong
President
Activate Chi Healthcare Ltd
Beauty Supplies & Equipment
206 6769 Dow Ave, Burnaby, BC V5H 3E1
(604) 629-8560
Wai Yip Wong
President
Activate Chi Healthcare Ltd
Beauty Supplies & Equipment
(604) 629-8560
Wai Tong Wong
President
LUK FOOK JEWELLERY & GOLDSMITH (USA) CO. LTD
185 Canal St Store A, New York, NY 10013
185 Canal St, New York, NY 10013
Wai Wong
Owner
Lucky Garden
Eating Place
143 Lafayette Ave, Staten Island, NY 10301
(718) 273-3228
Wai Wong
Director
Fatwire Corporation
Custom Computer Programing · Custom Computer Programming · Prepackaged Software · Prepackaged Software Services
330 Old Country Rd, Garden City, NY 11501
(516) 247-4500, (516) 248-2180, (516) 328-9473
Wai Y. Wong
Principal
Evergreen R.E. Management Inc
Management Services
20 Monroe St, New York, NY 10002
Wai S. Wong
Principal
Wong, Wai Suen
Business Services at Non-Commercial Site
1792 W 8 St, Brooklyn, NY 11223
Wai Wong
Manager
Bakery and Confectionery Training Institute of America, LLC

Publications

Isbn (Books And Publications)

Global Perspectives on Quality in Higher Education

View page
Author

Wai Sum Wong

ISBN #

0754618293

Clinical PET: Principals and Applications

View page
Author

Wai Hoi Wong

ISBN #

0387408541

Us Patents

Dihydropyridines And New Uses Thereof

View page
US Patent:
6608086, Aug 19, 2003
Filed:
Oct 5, 2001
Appl. No.:
09/972801
Inventors:
Charles Gluchowski - Wayne NJ
John M. Wetzel - Elmwood Park NJ
George Chiu - Bridgewater NJ
Mohammed R. Marzabadi - Ridgewood NJ
Wai C. Wong - Newark NJ
Dhanapalan Nagarathnam - Ramsey NJ
Assignee:
Synaptic Pharmaceutical Corporation - Paramus NJ
International Classification:
C07D40112
US Classification:
514318, 546194
Abstract:
This invention provides dihydropyridines useful for treatment of prostatic hyperplasia, inhibition of cholesterol synthesis, and/or reduction of intraocular pressure.

Oxazolidinones And Uses Thereof

View page
US Patent:
6620815, Sep 16, 2003
Filed:
Aug 10, 2000
Appl. No.:
09/636518
Inventors:
Bharat Lagu - Maywood NJ
T. G. Murali Dhar - Newark DE
Dhanapalan Nagarathnam - Ramsey NJ
Yoon T. Jeon - Ridgewood NJ
Mohammad R. Marzabadi - Ridgewood NJ
Wai C. Wong - Livingston NJ
Charles Gluchowski - Danville CA
Assignee:
Synaptic Pharmaceutical Corporation - Paramus NJ
International Classification:
A61K 31496
US Classification:
51425402, 51425401, 514326, 5142288, 514318, 514321, 514322, 544366, 544369, 544 96, 546208, 546209, 546210, 546194, 546199, 546198
Abstract:
This invention is directed to oxazolidinone compounds which are selective antagonists for human receptors. This invention is also related to uses of these compounds for lowering intraocular pressure, inhibiting cholesterol synthesis, relaxing lower urinary tract tissue, the treatment of benign prostatic hyperplasia, impotency, cardiac arrhythmia and for the treatment of any disease where the antagonism of the receptor may be useful. The invention further provides a pharmaceutical composition comprising a therapeutically effective amount of the above-defined compounds and a pharmaceutically acceptable carrier.

5-(Heterocyclic Alkyl)-6-Aryl-Dihydropyrimidines

View page
US Patent:
6727257, Apr 27, 2004
Filed:
Dec 5, 2000
Appl. No.:
09/730458
Inventors:
Dhanapalan Nagarathnam - Ramsey NJ
George Chiu - Bridgewater NJ
T. G. Murali Dhar - Newark DE
Wai C. Wong - Newark NJ
Mohammad R. Marzabadi - Ridgewood NJ
Charles Gluchowski - Danville CA
Bharat Lagu - Maywood NJ
Shou Wu Miao - Edison NJ
Assignee:
Synaptic Pharmaceutical Corporation - Paramus NJ
International Classification:
C07D40106
US Classification:
5142601, 5142651, 514274, 544230, 544280, 544278, 544316, 544395
Abstract:
This invention is directed to dihydropyrimidine compounds of the following formula: wherein A is which are selective antagonists for human receptors. This invention is also related to uses of these compounds for lowering intraocular pressure, inhibiting cholesterol synthesis, relaxing lower urinary tract tissue, the treatment of benign prostatic hyperplasia, impotence, cardiac arrhythmia and for the treatment of any disease where antagonism of the receptor may be useful. The invention further provides a pharmaceutical composition comprising a therapeutically effective amount of the above-defined compounds and a pharmaceutically acceptable carrier.

Imidazole And Imidazoline Derivatives And Uses Thereof

View page
US Patent:
6777426, Aug 17, 2004
Filed:
Aug 20, 2001
Appl. No.:
09/933106
Inventors:
Wai C. Wong - Newark NJ
Yoon T. Jeon - Ridgewood NJ
T. G. Murali Dhar - Newark DE
Charles Gluchowski - Danville CA
Assignee:
Synaptic Pharmaceutical Corporation - Paramus NJ
International Classification:
C07D23324
US Classification:
514310, 514313, 514401, 546143, 546159, 5483331
Abstract:
This invention is directed to novel imidazole and imidazoline derivatives which are selective agonists for cloned human adrenergic receptors. This invention is also related to the use of these compounds for the treatment of any disease where modulation of the receptors may be useful. The invention further provides for a pharmaceutical composition comprising a therapeutically effective amount of the above-defined compounds and a pharmaceutically acceptable carrier.

Selective Npy (Y5) Antagonists

View page
US Patent:
6989379, Jan 24, 2006
Filed:
Apr 21, 2000
Appl. No.:
10/009849
Inventors:
Mohammad R. Marzabadi - Ridgewood NJ, US
Wai C. Wong - Hamden CT, US
Stewart A. Noble - Wheeling IL, US
Manesh N. Desai - Nutley NJ, US
Assignee:
H. Lundbick A/S - Volby-Copenhagen
International Classification:
C07D 513/04
C07D 513/22
A61K 31/381
A61P 3/04
US Classification:
51421111, 540548, 548151, 514366
Abstract:
This invention is directed to triazine derivatives, bicyclic compounds and tricyclic compounds which are selective antagonists for a NPY (Y5) receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of a compound of this invention and a pharmaceutically acceptable carrier. This invention provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The invention further provides the use of a compound of the invention for the preparation of a pharmaceutical composition for treating an abnormality, wherein the abnormality is alleviated by decreasing the activity of a human Y5 receptor.

Selective Npy (Y5) Antagonists

View page
US Patent:
7273880, Sep 25, 2007
Filed:
Jan 20, 2005
Appl. No.:
11/040328
Inventors:
Mohammad R. Marzabadi - Ridgewood NJ, US
Wai C. Wong - Hamden CT, US
Stewart A. Noble - San Diego CA, US
Yasuchika Yamaguchi - Guilford CT, US
Assignee:
H. Lunbeck A/S - Copenhagen-Valby
Novartis AG - Basel
International Classification:
A61K 31/426
US Classification:
514370
Abstract:
This invention is directed to bicyclic and tricyclic compounds which are selective antagonists for NPY (Y5) receptors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of a compound of this invention and a pharmaceutically acceptable carrier. The invention provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides the use of a compound of the invention for the preparation of a pharmaceutical composition for treating an abnormality, wherein the abnormality is alleviated by decreasing the activity of a human Y5 receptor.

Dihydropyrimidines And Uses Thereof

View page
US Patent:
20020010186, Jan 24, 2002
Filed:
May 15, 2001
Appl. No.:
09/855597
Inventors:
Wai Wong - Newark NJ, US
Bharat Lagu - Maywood NJ, US
Dhanapalan Nagarathnam - Ramsey NJ, US
Mohammad Marzabadi - Ridgewood NJ, US
Charles Gluchowski - Danville CA, US
Assignee:
Synaptic Pharmaceutical Corporation
International Classification:
A61K031/519
A61K031/506
US Classification:
514/258000, 514/269000, 544/278000, 544/315000
Abstract:
This invention is directed to dihydropyrimidine compounds which are selective antagonists for human receptors. This invention is also related to uses of these compounds for lowering intraocular pressure, inhibiting cholesterol synthesis, relaxing lower urinary tract tissue, the treatment of benign prostatic hyperplasia, impotency, cardiac arrhythmia and for the treatment of any disease where the antagonism of the receptor may be useful. The invention further provides a pharmaceutical composition comprising a therapeutically effective amount of the above-defined compounds and a pharmaceutically acceptable carrier.

Selective Npy (Y5) Antagonists

View page
US Patent:
20050176709, Aug 11, 2005
Filed:
Apr 6, 2005
Appl. No.:
11/099960
Inventors:
Mohammad Marzabadi - Ridgewood NJ, US
Wai Wong - Hamden CT, US
Stewart Noble - San Diego CA, US
Manesh Desai - Nutley NJ, US
Assignee:
H. Lundbeck A/S - Valby-Copenhagen
International Classification:
A61K031/53
A61K031/4439
A61K031/43
C07D498/02
US Classification:
514241000, 544197000, 514366000, 514340000, 546270400, 548151000
Abstract:
This invention is directed to triazine derivatives, bicyclic compounds and tricyclic compounds which are selective antagonists for a NPY (Y5) receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of a compound of this invention and a pharmaceutically acceptable carrier. This invention provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The invention further provides the use of a compound of the invention for the preparation of a pharmaceutical composition for treating an abnormality, wherein the abnormality is alleviated by decreasing the activity of a human Y5 receptor.
Control profile
Wai Hung Wong from Kirkland, WA, age ~71 Get Report